Charles River Laboratories stock rises 1.91% and outperforms competitors

8 articles · Updated · MarketWatch · Apr 30

Shares closed at $166.97 on Thursday, ending a two-day losing streak as the S&P 500 gained 1.02% and the Dow rose 1.62%.
The stock remained 27.05% below its 52-week high of $228.88 reached on 13 January.
Against peers, Labcorp slipped 0.13%, while Alnylam gained 2.76% and Bio-Techne jumped 6.49%; trading volume of 702,818 was below its 50-day average.

With a negative P/E ratio and recent losses, why do analysts believe Charles River Labs stock is undervalued?

As competitors report record growth, can Charles River's sell-offs and AI innovations actually reverse its financial decline?